Cargando…

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore

PURPOSE: There is an unmet need for strategies to prevent atherosclerotic cardiovascular disease in Singapore. The main objective of this study was to investigate Singapore physicians’ response to the 2013 American College of Cardiology and American Heart Association (ACC/AHA) guidelines for treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Setia, Sajita, Fung, Selwyn Sze-Wang, Waters, David D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461017/ https://www.ncbi.nlm.nih.gov/pubmed/26082642 http://dx.doi.org/10.2147/VHRM.S82710

Ejemplares similares

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
por: Okerson, Ted, et al.
Publicado: (2017)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines
por: Matyori, Amro, et al.
Publicado: (2023)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
Publicado: (2016)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
por: Egan, Brent M., et al.
Publicado: (2016)

Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA Guidelines
por: Xia, Yiwei, et al.
Publicado: (2021)

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)

Comparison of application of 2013 ACC/AHA guideline and 2011 European Society of Cardiology guideline for the management of dyslipidemias for primary prevention in a Turkish cohort
por: Yılmaz, Mustafa, et al.
Publicado: (2017)

Statin Eligibility according to 2013 ACC/AHA and USPSTF Guidelines among Jordanian Patients with Acute Myocardial Infarction: The Impact of Gender
por: Ibdah, Rashid, et al.
Publicado: (2023)

Ambulatory and home blood pressure monitoring: gaps between clinical guidelines and clinical practice in Singapore
por: Setia, Sajita, et al.
Publicado: (2017)

2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population
por: Cho, Yun Kyung, et al.
Publicado: (2016)

Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline
por: Kibria, Gulam Muhammed Al, et al.
Publicado: (2018)

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
por: Wenger, Nanette K.
Publicado: (2019)

Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline
por: Hosseini, Mostafa, et al.
Publicado: (2019)

What is new in ACC/AHA 2017 focused update of valvular heart disease guidelines
por: Özkan, Mehmet
Publicado: (2017)

Society for Cardiovascular Magnetic Resonance perspective on the 2021 AHA/ACC Chest Pain Guidelines
por: Arai, Andrew E., et al.
Publicado: (2022)

The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cholesterol management and for cardiovascular risk stratification: A reappraisal
por: Bansal, Manish, et al.
Publicado: (2014)

Sex Differences in Statin Prescribing in Diabetic and Heart Disease Patients in FQHCs: A Comparison of the ATPIII and 2013 ACC/AHA Cholesterol Guidelines
por: Khan, Nazia Naz S., et al.
Publicado: (2019)

2013 ACC/AHA versus 2004 NECP ATP III Guidelines in the Assignment of Statin Treatment in a Korean Population with Subclinical Coronary Atherosclerosis
por: Jung, Chang Hee, et al.
Publicado: (2015)

Examination of physicians’ adherence to the 2013 ACC/AHA statin/cholesterol guidelines using a framework of awareness to adherence: A cross-sectional study
por: Fleming, Marc L, et al.
Publicado: (2020)

Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh
por: Rahman, Md. Ashfikur, et al.
Publicado: (2021)

Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines
por: Jan, Ya-Ting, et al.
Publicado: (2021)

2021 ACC/AHA/SCAI Coronary Artery Revascularization Guidelines for Managing the Nonculprit Artery in STEMI
por: Don, Creighton W., et al.
Publicado: (2022)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline
por: Alanaeme, Chibuike J., et al.
Publicado: (2022)

Trends in Statin Use 2009–2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol
por: Harrison, Teresa N., et al.
Publicado: (2018)

Subclinical Coronary Atherosclerosis: Implication of Coronary Computed Tomography Angiography Findings among Statin Candidates according to the 2013 ACC/AHA Cholesterol Management Guidelines
por: Seo, Jiwoon, et al.
Publicado: (2019)

Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline
por: Lee, Ji Hyun, et al.
Publicado: (2018)

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
por: Asgari, Samaneh, et al.
Publicado: (2019)

MitraClip for Secondary Mitral Regurgitation: Approach to the 2020 ACC/AHA Valvular Heart Disease Guidelines
por: McCauley, Brian D., et al.
Publicado: (2020)

Putting the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization Into Practice: A Case Series
por: Bittl, John A., et al.
Publicado: (2021)

Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
por: Kittleson, Michelle M., et al.
Publicado: (2014)

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman J., et al.
Publicado: (2021)

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
por: Jensen, Michael D., et al.
Publicado: (2013)

Ambulatory Holter monitoring in asymptomatic patients with DDD pacemakers – do we need ACC/AHA Guidelines revision?
por: Chudzik, Michal, et al.
Publicado: (2013)

Overdiagnosis or not? 2017 ACC/AHA high blood pressure clinical practice guideline: Consequences of intellectual conflict of interest
por: Miyazaki, Kei
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_as4qjdjmsmkrtam66u7fhitkuj